Busey Bank Boosts Position in McKesson Corporation

Institutional investor increases stake in pharmaceutical distributor

Apr. 20, 2026 at 8:26am

A highly detailed, black-and-white macro photograph of the inner workings of industrial banking equipment, conveying a sense of the secure, physical infrastructure that underpins the financial system.An extreme close-up of the intricate gears and mechanisms that power the financial industry's distribution networks highlights the institutional strength behind McKesson's pharmaceutical supply chain.Irving Today

Busey Bank, an institutional investor, significantly increased its position in shares of McKesson Corporation, a major pharmaceutical distribution and healthcare services company, during the fourth quarter. The bank now owns over 10,000 shares of McKesson's stock, worth approximately $8.5 million.

Why it matters

This transaction highlights the continued interest and investment in McKesson from institutional investors, reflecting the company's strong performance and position in the healthcare distribution industry. McKesson's scale, diversified business model, and growth potential make it an attractive investment for large institutional players like Busey Bank.

The details

According to a recent SEC filing, Busey Bank boosted its position in McKesson Corporation by 1,749.8% during the fourth quarter of 2025. The bank now owns 10,322 shares of McKesson's stock, up from just 558 shares held previously. This increased stake is valued at approximately $8.47 million based on McKesson's closing stock price at the end of the reporting period.

  • Busey Bank increased its McKesson holdings during the fourth quarter of 2025.

The players

Busey Bank

An institutional investor that significantly increased its stake in McKesson Corporation.

McKesson Corporation

A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and healthcare technology solutions.

Got photos? Submit your photos here. ›

The takeaway

Busey Bank's substantial increase in its McKesson holdings underscores the continued institutional investor confidence in the pharmaceutical distributor's business model and growth prospects. This transaction reflects the broader trend of large investors seeking exposure to leading healthcare distribution companies like McKesson.